中文产业新闻评分64Chinese source
大睿生物授予罗氏超 11 亿美元全球许可，基于肝外递送平台开发 ALK7 siRNA 肥胖症疗法
超 11 亿美元！国产 siRNA 授权罗氏
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.
超 11 亿美元！国产 siRNA 授权罗氏
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.